ROIV
Roivant Sciences Ltd. · Healthcare
President and CIO Mayukh Sukhatme sold $24.2M of Roivant Sciences Ltd.
Sold$24,160,402
$36.34Price
664,826Shares
−3%Stake
What ROIV did after the filing
- The stock from Wed, Aug 19 open, $37.83
- −6.2%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Oct 1 close.
Traded Fri, Aug 14. Filed Tue, Aug 18, 9:00 PM ET, after the close. Returns use the Aug 19 open and the Oct 1 close. Not investment advice.